In this Vet Times Podcast, Leanne Dobrowolski joins Paul Imrie to discuss how physiotherapy is growing in importance in management of chronic pain cases, and offers advice on training as a veterinary physiotherapist. 𝗟𝗘𝗔𝗡𝗡𝗘 𝗗𝗢𝗕𝗥𝗢𝗪𝗢𝗟𝗦𝗞𝗜 𝗠𝗦𝗰𝗩𝗲𝘁𝗣𝗵𝘆𝘀, 𝗔𝗱𝘃𝗖𝗲𝗿𝘁𝗩𝗣𝗵𝘆𝘀, 𝗖𝗲𝗿𝘁𝗖𝗹𝗶𝗻𝗘𝗱(𝗠𝗱𝘅), 𝗕𝗦𝗰(𝗛𝗼𝗻𝘀), 𝗙𝗱𝗦𝗰, 𝗥𝗩𝗡, 𝗟𝟯𝗖𝗲𝗿𝘁𝗛𝘆𝗱𝗿𝗼𝗦𝗔, 𝗠𝗜𝗥𝗩𝗔𝗣, 𝗖𝗖 Leanne has worked in veterinary medicine since 2008 and graduated from Nottingham Trent University in 2013 as an RVN. Once qualified, Leanne established a keen interest in animal rehabilitation and volunteered with wildlife in South Africa, Costa Rica and Thailand. Leanne’s passion for rehabilitation developed and this led to her completing a Master of Science in Veterinary Physiotherapy at the University of Nottingham and a level 3 certificate in hydrotherapy at K9 Hydro Services. Leanne now has her own veterinary physiotherapy and hydrotherapy clinic in Peterborough, Healing Hands Animal Physiotherapy. 𝗦𝗣𝗢𝗡𝗦𝗢𝗥𝗘𝗗 This podcast is brought to you by Galliprant, from Elanco. As the only piprant-class NSAID, Galliprant is the most targeted oral treatment for canine OA. With the power to precisely target OA pain, Galliprant can be used from first diagnosis and for as long as needed, even in young dogs. As recent data shows, OA is much more common in young dogs than first thought. This new study revealed that 41% of young dogs had radiographic OA, and two-thirds of those had associated pain. Based on this insight, early intervention in young dogs could improve quality of life for years to come. As the most targeted oral treatment for canine OA, Galliprant can play a key role in this early stage of OA management. Hear expert opinion on this new data and what it could mean for young dogs with OA at www.myelanco.co.uk/brand/galliprant-hear-the-experts

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related